相关实验视频
Updated: Sep 10, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
癌症治疗中的CAR细胞衍生外体:生物发生,工程策略和抗瘤机制
Chaohua Si1, Yuanyuan Li1, Yunwen Wang1
1National Research Institute for Family Planning, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100000, China.
化学抗原受体 (CAR) 细胞衍生外体显示出更安全,更容易获得的癌症疗法. 这些外体保留了杀伤瘤的能力,并且可以与其他治疗相结合,以提高疗效和减少副作用.
科学领域:
- 癌症学
- 免疫疗法
- 纳米医学
背景情况:
- 化学抗原受体 (CAR) 细胞治疗,包括CAR T,CAR NK和CAR巨细胞,对瘤,特别是血液恶性瘤有效.
- 汽车细胞疗法面临制造方面的挑战,并存在诸如细胞因子释放综合征 (CRS) 等严重不良事件的风险.
- 来自CAR细胞的外体对传统CAR细胞治疗具有潜在的优势.
研究的目的:
- 审查CAR细胞衍生外体的生物发生,工程和抗瘤机制.
- 讨论CAR细胞衍生外体在癌症治疗中的临床证据和潜力.
- 探索CAR细胞衍生外体与其他抗瘤方式的组合策略.
主要方法:
- 对CAR细胞衍生外体的现有文献的审查.
- 对外基因组修饰的生物发生路径和工程策略的分析.
- 对抗瘤疗效和安全性的临床前和临床数据的评估.
主要成果:
- 来自CAR细胞的外体保留了母CAR细胞的瘤杀伤功能.
- 外体提供实用的好处:可用性,安全性和易于储存/运输.
- 使用CAR细胞衍生外体的组合方法提高了疗效,减少了副作用.
结论:
- 从CAR细胞衍生出来的外体是有前途的下一代癌症治疗药物.
- 它们的固有安全性和多功能性促进了临床转换和组合疗法.
- 需要进一步的研究和临床研究才能充分发挥其治疗潜力.
更多相关视频
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
相关概念视频
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Mesenchymal Stem Cells
Tumor Immunotherapy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Targeted Cancer Therapies
There are several types of targeted therapies against...